RecruitingPhase 2Phase 3NCT06296082

Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity

Comparative Study of the Mechanism of Action of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity: a Proof of Concept Controlled Trial


Sponsor

Universiteit Antwerpen

Enrollment

90 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized parallel group clinical trial which will be conducted in three countries (Spain, Canada and Belgium) comparing Botulinum Toxin type A (BTX-A) and Dry Needling (DN) effectiveness for post-stroke spasticity in participants who had a first stroke in the previous 12 months and have plantar flexor spasticity. Participants will be randomly allocated to receive either one session of BTX-A or 12 weekly sessions of DN. Blinded evaluators will assess the effects before, during, and after treatment, and at a 4-week follow-up.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria7

  • aged 18-75 years.
  • post-stroke spasticity in ankle plantar flexors (Modified Ashworth Scale (MAS) scores of 1-2).
  • first stroke.
  • 0-12 months evolution.
  • no previous BTX-A or DN treatment for spasticity.
  • ankle passive range of motion ≥ 20° (approximately) with knee flexion ~30°.
  • independent ambulation with or without aids.

Exclusion Criteria4

  • medical conditions interfering with data interpretation.
  • contraindications for BTX-A or DN treatment.
  • changes in anti-spasticity medication dosage (if appropriate), either during the trial or within the 3 months prior to participation.
  • pregnant or breastfeeding.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBotulinum toxin type A

Botulinum toxin type A injections are a treatment technique to treat the spastic muscles in patients with stroke that targets on the neuromuscular endplate zone provoking a chimical disruption of dysfunctional endplates.

OTHERDry Needling

Dry Needling is a treatment technique to treat the spastic muscles in patients with stroke that targets on the neuromuscular endplate zone provoking a mechanical disruption of dysfunctional endplates.


Locations(3)

Universiteit Antwerpen

Antwerp, Flanders, Belgium

Jewish Rehabilitation Hospital

Montreal, Quebec, Canada

Hospital Clínico Universitario Lozano Blesa

Zaragoza, Zaragoza, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06296082


Related Trials